In comparison with the nontreated patients, Tα1 significantly reduced the mortality rate of infected patients, and effectively restored T cell numbers in patients with severe lymphocytopenia (CD8+ T cells < 400/μL, CD4+ T cells < 650/μL). This evidence concerns the gene CD8A and lymphopenia.